viernes, 26 de junio de 2015

Announcing Chinese Journal of Cancer's first Impact Factor

Chinese Journal of Cancer  Impact Factor
Editor-in-Chief: Yi-Xin Zeng (China)
Submit a manuscriptEditorial BoardAuthor InstructionsArticle Alerts
We are very pleased to announce that the open access journal Chinese Journal of Cancerhas received its first Impact Factor of 2.16.
Read these influential articles and submit your next manuscript to the journal.
Influential Articles:
Cancer research in the era of next-generation sequencing and big data calls for intelligent modelling
Cytokine-induced killer (CIK) cells: from basic research to clinical translation
ATP-binding cassette subfamily B member 1 (ABCB1) and subfamily C member 10 (ABCC10) are not primary resistance factors for cabazitaxel
Association of the Asp312Asn and Lys751Gln polymorphisms in the XPD gene with the risk of non-Hodgkin’s lymphoma: evidence from a meta-analysis
Impact of oral anti-hepatitis B therapy on the survival of patients with hepatocellular carcinoma initially treated with chemoembolization
The Benefits of Publishing with Us:
  • High quality peer-review service
  • Expert Editorial Board
  • Rapid publication upon acceptance
  • Widest possible global dissemination of your research
  • Inclusion in a number of relevant full-text repositories
    Please forward this email and share the good news.
    Kind regards,
    The BioMed Central Team

    No hay comentarios:

    Publicar un comentario